Correlation Between GainClients and Cannara Biotech
Can any of the company-specific risk be diversified away by investing in both GainClients and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GainClients and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GainClients and Cannara Biotech, you can compare the effects of market volatilities on GainClients and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GainClients with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of GainClients and Cannara Biotech.
Diversification Opportunities for GainClients and Cannara Biotech
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GainClients and Cannara is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding GainClients and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and GainClients is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GainClients are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of GainClients i.e., GainClients and Cannara Biotech go up and down completely randomly.
Pair Corralation between GainClients and Cannara Biotech
If you would invest 51.00 in Cannara Biotech on September 29, 2024 and sell it today you would earn a total of 4.00 from holding Cannara Biotech or generate 7.84% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 90.91% |
Values | Daily Returns |
GainClients vs. Cannara Biotech
Performance |
Timeline |
GainClients |
Cannara Biotech |
GainClients and Cannara Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GainClients and Cannara Biotech
The main advantage of trading using opposite GainClients and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GainClients position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.GainClients vs. NextPlat Corp | GainClients vs. Waldencast Acquisition Corp | GainClients vs. CXApp Inc | GainClients vs. Alkami Technology |
Cannara Biotech vs. Genesis Electronics Group | Cannara Biotech vs. Nextmart | Cannara Biotech vs. Goff Corp | Cannara Biotech vs. GainClients |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |